Peptazol 40 40 mg Enteric coated tablets
PDF Leaflet Revision Date: 9 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of duodenal ulcer, gastric ulcer, reflux oesophagitis, and Zollinger-Ellison syndrome.
Dosage (summary)
One tablet daily in the morning for 2-8 weeks depending on condition.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; use with caution.
Key Drug Interactions
- HIV protease inhibitors
- Methotrexate
- CYP2C19 inhibitors
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Children
Common side effects
- Diarrhoea
- Headache
- Dizziness
Counselling Points
- Take in the morning before breakfast
- Do not crush or chew tablets
- Monitor for signs of renal issues
Serious warnings
- Possible malignancy
- Risk of hypomagnesaemia
- Increased risk of fractures
Important Disclaimer
The Peptazol 40 40 mg Enteric coated tablets professional information leaflet below is the property of Pharmacorp and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
